NYSEAMERICAN:INUV - Inuvo Stock Price, Forecast & News

Inuvo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INUV."

Inuvo Inc (NYSEAMERICAN:INUV) posted its quarterly earnings data on Wednesday, August, 14th. The technology company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.07. The technology company had revenue of $14.05 million for the quarter, compared to analysts' expectations of $13.30 million. View Inuvo's Earnings History.

Inuvo is scheduled to release their next quarterly earnings announcement on Friday, March 20th 2020. View Earnings Estimates for Inuvo.

News stories about INUV stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Inuvo earned a news impact score of 2.0 on InfoTrie's scale. They also gave media coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Inuvo.

Inuvo saw a decline in short interest during the month of February. As of February 14th, there was short interest totalling 235,800 shares, a decline of 53.0% from the January 30th total of 502,100 shares. Based on an average daily trading volume, of 409,100 shares, the short-interest ratio is currently 0.6 days. Currently, 0.5% of the shares of the company are sold short. View Inuvo's Current Options Chain.

Some companies that are related to Inuvo include Trimantium Growthops (TGO), cbdMD (YCBD), I Synergy Group (IS3), Ebiquity (EBQ), Arena Events Group (ARE), NAHL Group (NAH), System1 Group (SYS1), Tech Mpire (TMP), Engage:BDR (EN1), Be Heard Group (BHRD), Grand Vision Media (GVMH), BlueRush (BTV), Matomy Media Group (MTMY), Jaywing (JWNG) and XTD (XTD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inuvo investors own include NovaBay Pharmaceuticals (NBY), Ceragon Networks (CRNT), Opko Health (OPK), Biocept (BIOC), Nokia Oyj (NOK), BIOLASE (BIOL), CTI BioPharma (CTIC), Gevo (GEVO), Actinium Pharmaceuticals (ATNM) and Adamis Pharmaceuticals (ADMP).

Inuvo's stock is owned by many different of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (5.47%). View Institutional Ownership Trends for Inuvo.

INUV stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Inuvo.

Shares of INUV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of INUV stock can currently be purchased for approximately $0.27.

Inuvo has a market capitalization of $13.23 million. Inuvo employs 60 workers across the globe.View Additional Information About Inuvo.

The official website for Inuvo is http://inuvo.com/.

Inuvo's mailing address is 500 President Clinton Ave Ste 300, LITTLE ROCK, AR 72201-1760, United States. The technology company can be reached via phone at +1-501-2058508.